Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Aim: Our aim was to describe the epidemiology of multisystem inflammatory syndrome in children (MIS-C) in the Republic of Ireland, in the context of all cases of COVID-19 in children, during the first year of the SARS-CoV-2 pandemic.
Methods: Cases of MIS-C were identified by prospective surveillance in Irish hospitals from April 2020 to April 2021. Paediatric COVID-19 cases and outbreaks in schools or childcare facilities were notified to and routinely investigated by Public Health. Univariate and bivariate analyses were carried out in Excel, Stata and JMP statistical package.
Results: Fifty-four MIS-C cases (median age 7.58 years; males 57%) were identified over the study period. MIS-C incidence was higher in certain ethnicities ('black' 21.3/100,000 [95% CI 4.3-38.4]; and 'Irish Traveller' 14.7/100,000 [95% CI -5.7-35.1]) than those of 'white' ethnicity (3.4 /100,000). MIS-C cases occurred in three temporal clusters, which followed three distinct waves of community COVID-19 infection, irrespective of school closures. Formal contact tracing identified an epidemiological link with a COVID-19-infected family member in the majority of MIS-C cases (77%). In contrast, investigation of COVID-19 school outbreaks demonstrated no epidemiological link with MIS-C cases during the study period.
Conclusion: Efforts at controlling SARS-CoV-2 transmission in the community may be a more effective means to reduce MIS-C incidence than school closures. Establishing a mandatory reporting structure for MIS-C will help delineate the role of risk factors such as ethnicity and obesity and the effect of vaccination on MIS-C incidence.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538218 | PMC |
| http://dx.doi.org/10.1111/apa.16531 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical characteristics and factors associated with severe COVID-19 among hospitalized pediatric patients: a retrospective cohort study in the Chaoshan region of China.
Front Pediatr
August 2025
Department of Pediatrics, Shantou Central Hospital, Shantou, Guangdong, China.
Background: Since 2019, COVID-19 has substantially impacted global public health. Although pediatric cases generally manifest with mild symptoms, severe and even fatal outcomes have occurred. Despite the decreased viral transmissibility and pathogenicity observed in the post-pandemic era, identifying early clinical indicators for severe pediatric COVID-19 remains crucial.
View Article and Find Full Text PDFRe-engineering a machine learning phenotype to adapt to the changing COVID-19 landscape: a machine learning modelling study from the N3C and RECOVER consortia.
Lancet Digit Health
August 2025
Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA. Electronic address:
Background: In 2021, we used the National COVID Cohort Collaborative (N3C) as part of the National Institutes of Health RECOVER Initiative to develop a machine learning pipeline to identify patients with a high probability of having post-acute sequelae of SARS-CoV-2 infection or long COVID. However, the increased home testing, missing documentation, and reinfections that characterise the pandemic beyond 2022 necessitated the re-engineering of our original model to account for these changes in the COVID-19 research landscape.
Methods: Trained on 72 745 patient records (36 238 with long COVID and 36 507 with no evidence of long COVID), our updated XGBoost model gathered data for each patient in overlapping 100-day periods that progressed through time and issued a probability of long COVID for each 100-day period.
Genetic Variants Affect Distinct Metabolic Pathways in Pediatric Multisystem Inflammatory Syndrome and Severe COVID-19.
J Med Virol
August 2025
Instituto Carlos Chagas, FIOCRUZ, Curitiba, Paraná, Brazil.
The coronavirus disease 2019 (COVID-19) pandemic has triggered a global health crisis, with over 700 million confirmed cases and at least 7 million deaths reported by early 2024. Children are less vulnerable to severe SARS-CoV-2 infection than adults and typically experience milder respiratory symptoms. However, a rare but significant complication, known as multisystem inflammatory syndrome in children (MIS-C), can develop weeks after infection, characterized by a spectrum of inflammatory symptoms.
View Article and Find Full Text PDFLong-Term Follow-Up of Cardiac Magnetic Resonance Imaging in Children with MIS-C Associated With COVID-19: A Prospective Study.
Klin Padiatr
August 2025
Radiology, Bezmialem Vakif University, Istanbul, Turkey.
Background: The researchers identified cases of multisystem inflammatory syndrome in children (MIS-C), which was linked to COVID-19 starting in 2020. MIS-C is associated with significant cardiovascular morbidity in the acute phase. A small number of articles in the literature have recorded the long-term myocardial effects of MIS-C patients in children treated in pediatric intensive care units (PICUs).
View Article and Find Full Text PDFMultisystem inflammatory syndrome in children (MIS-C) with secondary intestinal cytomegalovirus infection: A case report.
Diagn Microbiol Infect Dis
December 2025
Critical Care Medicine, Guangxi Zhuang Autonomous Region Maternal and Child Health Hospital, Nanning 530000, China.
Multisystem inflammatory syndrome in children (MIS-C) constitutes a severe pediatric disorder temporally linked to SARS-CoV-2 infection. Although SARS-CoV-2 may induce cytomegalovirus (CMV) reactivation, MIS-C cases with secondary intestinal CMV infection are exceptionally rare. We describe a pediatric patient with MIS-C treated initially with intravenous immunoglobulin (IVIG) and methylprednisolone, following clinical improvement, sudden high fever and worsening abdominal symptoms occurred.
View Article and Find Full Text PDF